Literature DB >> 12786838

Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection.

V Descamps1, E Mahe, N Houhou, L Abramowitz, F Rozenberg, S Ranger-Rogez, B Crickx.   

Abstract

Association of drug-induced hypersensitivity syndrome with viral infection is debated. Human herpesvirus 6 (HHV-6) reactivation has been the most frequently reported infection associated with this syndrome. However, a case of cytomegalovirus (CMV) infection was recently described associated with anticonvulsant-induced hypersensitivity syndrome. We report a case of severe allopurinol-induced hypersensitivity syndrome with pancreatitis associated with Epstein-Barr virus (EBV) infection. Active EBV infection was demonstrated in two consecutive serum samples by the presence of anti-EBV early antigen (EA) IgM antibodies and an increase in anti-EBV EA IgG antibodies, whereas no anti-EBV nuclear antigen IgG antibodies were detected. EBV DNA was detected by polymerase chain reaction (PCR) in peripheral blood mononuclear cells. Reactivation of HHV-6 was suggested only by the presence of anti-HHV-6 IgM antibodies, but HHV-6 DNA was not detected by PCR in the serum. Other viral investigations showed previous infection (CMV, rubella, measles, parvovirus B19), immunization after vaccination (hepatitis B virus), or absence of previous infection (hepatitis C virus, human immunodeficiency virus). We suggest that EBV infection may participate in some cases, as do the other herpesviruses HHV-6 or CMV, in the development of drug-induced hypersensitivity syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12786838     DOI: 10.1046/j.1365-2133.2003.05330.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  20 in total

Review 1.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

2.  Lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) during primary Epstein-Barr virus (EBV) infection.

Authors:  Ibrahim Tawhari; Fawaz Tawhari; Mossab Aljuaid
Journal:  BMJ Case Rep       Date:  2018-01-23

3.  Isolated ileal perforation due to cytomegalovirus reactivation during management of terbinafine hypersensitivity.

Authors:  Soichi Sano; Hiroki Ueno; Keiko Yamagami; Yosuke Yakushiji; Yoshihiro Isaka; Isao Kawasaki; Masashi Takemura; Takeshi Inoue; Masayuki Hosoi
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

Review 4.  Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review.

Authors:  Ivan Gentile; Maria Talamo; Guglielmo Borgia
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

Review 5.  Recent advances in the understanding of severe cutaneous adverse reactions.

Authors:  N R Adler; A K Aung; E N Ergen; J Trubiano; M S Y Goh; E J Phillips
Journal:  Br J Dermatol       Date:  2017-09-29       Impact factor: 9.302

6.  Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus.

Authors:  Atsushi Komatsuda; Yohsuke Okamoto; Takashi Hatakeyama; Hideki Wakui; Ken-ichi Sawada
Journal:  Clin Rheumatol       Date:  2007-10-19       Impact factor: 2.980

Review 7.  Occupational trichloroethylene exposure as a cause of idiosyncratic generalized skin disorders and accompanying hepatitis similar to drug hypersensitivities.

Authors:  Michihiro Kamijima; Naomi Hisanaga; Hailan Wang; Tamie Nakajima
Journal:  Int Arch Occup Environ Health       Date:  2006-11-15       Impact factor: 2.851

Review 8.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

Review 9.  Adverse cutaneous drug eruptions: current understanding.

Authors:  W Hoetzenecker; M Nägeli; E T Mehra; A N Jensen; I Saulite; P Schmid-Grendelmeier; E Guenova; A Cozzio; L E French
Journal:  Semin Immunopathol       Date:  2015-11-09       Impact factor: 11.759

Review 10.  A complex interaction between drug allergy and viral infection.

Authors:  Tetsuo Shiohara; Yoko Kano
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.